Email this page
Print this page
Reviews
Application of Regenerative Medicine for Kidney Diseases
Takashi Yokoo, Aikira Fukui and Eiji Kobayashi
Volume 3, Issue 1jan/feb/march 2007
Subscribe to this journal for $59/year
Following recent advancements of stem cell research, the potential for organ regeneration using somatic stem cells as an ultimate therapy for organ failure has increased. However, anatomically complicated organs such as the kidney and liver have proven more refractory to stem cell-based regenerative techniques. At present, kidney regeneration is considered to require one of two approaches depending on the type of renal failure, namely acute renal failure (ARF) and chronic renal failure (CRF).
The kidney has the potential to regenerate itself provided that the damage is not too severe and the kidney’s structure remains intact. Regenerative medicine for ARF should therefore aim to activate or support this potent. In cases of the irreversible damage to the kidney, which is most likely in patients with CRF undergoing long-term dialysis, self-renewal is totally lost. Thus, regenerative medicine for CRF will likely involve the establishment of a functional whole kidney de novo. This article reviews the challenges and recent advances in both approaches and discusses the potential approach of these novel strategies for clinical application.
Authors
Takashi Yokoo
The Jikei University School of Medicine; Tokyo, Japan
Aikira Fukui
The Jikei University School of Medicine; Tokyo, Japan
Eiji Kobayashi
The Jikei University School of Medicine; Tokyo, Japan
